This federal contract award, valued at $3,103.76, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Dupixent 300 mg/2 ml syringe (2 ml) and has an ultimate completion date of November 18, 2024.
Amerisourcebergen holds significant Indefinite Delivery Contracts (IDCs) with the DLA Troop Support Medical, valued at $999,999,999 through November 2026, and the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies, serving the healthcare needs of military personnel, veterans, and other federal beneficiaries. The contract award reviewed was not designated with any set-aside requirements, indicating open competition.
Generated 2/14/25, 9:22 AM